15-DEOXY-??12,14-PROSTAGLANDIN J2 (15D-PGJ2), A PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ?? LIGAND, REDUCES TISSUE LEUKOSEQUESTRATION AND MORTALITY IN ENDOTOXIC SHOCK
- 1 July 2005
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Shock
- Vol. 24 (1), 59-65
- https://doi.org/10.1097/01.shk.0000167108.88376.f2
Abstract
Peroxisome proliferator-activated receptor-γ (PPARγ) is a nuclear receptor that requires ligand activation for transcription. Experimental studies have shown that 15-deoxy-Δ12,14-PGJ2 (15d-PGJ2) is a natural PPARγ ligand which has potent anti-inflammatory properties. This study was designed to examine the effect and the molecular mechanisms of 15d-PGJ2 on tissue neutrophil infiltration and survival in endotoxic shock. Male Swiss albino mice were subjected to intraperitoneal injection of Escherichia coli lipopolysaccharide (LPS, 25 mg/kg). Three hours after LPS mice received vehicle or 15d-PGJ2 (1 mg/kg) and continued treatment every 12 hours. Survival was monitored for 72 hours. In a separate experiment, mice were sacrificed 6 hours after LPS and tissue examined. In vehicle-treated mice, LPS injection resulted in a survival rate of 9%. Marked lung injury was characterized by hemorrhage, infiltration of inflammatory cells and reduction of alveolar space. Elevated levels of myeloperoxidase activity in lung and small intestine were indicative of infiltration of neutrophils. Increased expression of intercellular adhesion molecule-1, vascular cellular adhesion molecule-1 and E-selectin were observed in the lung and small intestine. These inflammatory events were associated with reduced expression of PPARγ and with activation of nuclear factor-κB (NF-κB) in the lung. Treatment with 15d-PGJ2 improved survival rate to 55%, downregulated expression of adhesion molecules and reduced neutrophil infiltration in tissues. These beneficial effects were associated with reduced activation of NF-κB DNA binding, whereas expression and DNA binding of PPARγ and expression of the cytoprotective heat shock protein (HSP) 70 were increased in the lung. Our data demonstrate that 15d-PGJ2 ameliorates endotoxic shock most likely through repressing the proinflammatory pathway of NF-κB and enhancement of the cytoprotective heat shock response.Keywords
This publication has 33 references indexed in Scilit:
- PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-?? IS A NEW THERAPEUTIC TARGET IN SEPSIS AND INFLAMMATIONShock, 2005
- Peroxisome Proliferator Activator Receptor-γ Ligands, 15-Deoxy-Δ12,14-Prostaglandin J2 and Ciglitazone, Reduce Systemic Inflammation in Polymicrobial Sepsis by Modulation of Signal Transduction PathwaysThe Journal of Immunology, 2003
- PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA AGONISTS MODULATE MACROPHAGE ACTIVATION BY GRAM-NEGATIVE AND GRAM-POSITIVE BACTERIAL STIMULIShock, 2003
- Nuclear factor-κB as a therapeutic target in critical care medicineCritical Care Medicine, 2003
- Markers of endothelial damage in organ dysfunction and sepsisCritical Care Medicine, 2002
- Anti-inflammatory actions of 15-deoxy-delta 12,14-prostaglandin J2 and troglitazone: evidence for heat shock-dependent and -independent inhibition of cytokine-induced inducible nitric oxide synthase expression.Diabetes, 2000
- Modulation of Vascular Inflammation In Vitro and In Vivo by Peroxisome Proliferator–Activated Receptor-γ ActivatorsCirculation, 2000
- The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activationNature, 1998
- PPAR-γ agonists inhibit production of monocyte inflammatory cytokinesNature, 1998
- PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS: A Nuclear Receptor Signaling Pathway in Lipid PhysiologyAnnual Review of Cell and Developmental Biology, 1996